Favorable outcome associated with an IGF-1 ligand signature in breast cancer
- 2 February 2012
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 133 (1) , 321-331
Abstract
The insulin-like growth factor (IGF) axis is fundamentally important in cell growth, development and cancer. We used genomic technologies to better characterize the activity of the IGF axis in human breast cancer and to identify predictors of response to IGF targeted therapies. Analysis of the gene expression patterns and pathway analysis in 204 clinically annotated primary breast cancers were performed and compared to levels of mRNA for IGF ligands and receptors. Pathway activation scores were calculated by Pearson correlation (+1, −1). Network analysis was performed using Ingenuity software. IGF-1 ligand levels were strongly negatively correlated (P < 10−6) with a published IGF-IR activation signature. A signature of high IGF-1 ligand was associated with better prognosis (P = 0.025–1.5 × 10−8) in several public datasets. Pathway analysis revealed upregulation of pathways associated with breast differentiation (adipocyte growth factors, PPAR-gamma) and down-regulation of proliferation pathways (AKT/MAPK) in the IGF-1 ligand high group. Of note, the IGF-1 ligand signature was anti-correlated with IGFIR receptor levels (P = 0.07). In conclusion, a breast tumor-derived signature of high IGF-1 ligand is associated with favorable outcome, in contrast to a previously reported IGF-IR activation signature. The prognostic value of the IGF-I ligand signature is validated in three independent datasets. These signatures should be applied in study of IGF1-R targeted therapy.Keywords
This publication has 38 references indexed in Scilit:
- Insulin-Like Growth Factor-I Activates Gene Transcription Programs Strongly Associated With Poor Breast Cancer PrognosisJournal of Clinical Oncology, 2008
- Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristicsBreast Cancer Research and Treatment, 2008
- lumi: a pipeline for processing Illumina microarrayBioinformatics, 2008
- Model-based variance-stabilizing transformation for Illumina microarray dataNucleic Acids Research, 2008
- Bioconductor: open software development for computational biology and bioinformaticsGenome Biology, 2004
- Insulin-like growth factors and neoplasiaNature Reviews Cancer, 2004
- A Dominant Negative Type I Insulin-like Growth Factor Receptor Inhibits Metastasis of Human Cancer CellsJournal of Biological Chemistry, 2004
- Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray ExperimentsStatistical Applications in Genetics and Molecular Biology, 2004
- Development of New Insulin-like Growth Factor-1 Receptor Kinase Inhibitors Using Catechol MimicsJournal of Biological Chemistry, 2003
- Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptorOncogene, 2003